Development of a new immunochemistry method using antibodies of proteins related bile duct cancer in the bile duct cancer cell; pilot study
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0003285
- Lead Sponsor
- Yonsei University Health System, Gangnam Severance Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1. Patients with biliary cancer confirmed by imaging (CT, MRI, PET-CT)
2. Patients with bile duct cancer diagnised using brushing cytology by endoscopic retrograde pancreaticoduodenoscopy
3. Patients who underwent surgical treatment with biliary cancer
4. Patients with extrahepatic bile duct stenosis
Exclusion Criteria
1. Minors under the age of 19, vulnerable subjects such as illiteracy
2. Excludes necrotic specimens
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of differentiation power between conventional staining method and new staining by degree of expression in new immunochemistry staining using antibodies of aminoacyl-tRNA synthetases group and aminoacyl-tRNA synthetases-interacting multifunctional protein2 lacking exon 2 in the bile duct cancer cell and normal bile duct tissue
- Secondary Outcome Measures
Name Time Method Efficacy of staining method(the sensitivity, specificity, accuracy, positive predictive value and negative predictive value)